Healthcare Sector Stocks
The Healthcare sector has a total of 1051 stocks, with a combined market cap of $9.07 trillion, total revenue of $4.61 trillion and a weighted average PE ratio of 44.77.
Market Cap
9.07T
Revenue
4.61T
Profits
202.6B
PE Ratio
44.77
Profit Margin
4.40%
Dividend Yield
0.39%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.07T | 0.13% | 1,593,653 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 640.91B | 0.97% | 9,647,871 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 453.91B | -0.94% | 5,404,809 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 379.28B | -0.74% | 4,616,624 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 322.95B | -0.24% | 6,910,339 | 65.77B |
| 6 | NVS | Novartis AG | 298.51B | 0.71% | 1,620,400 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 265.99B | 0.22% | 3,861,406 | 61.37B |
| 8 | NVO | Novo Nordisk A/S | 219.77B | 1.85% | 6,806,082 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 207.93B | -1.54% | 1,962,048 | 46.34B |
| 10 | AMGN | Amgen Inc. | 203.07B | 0.06% | 2,903,316 | 37.22B |
| 11 | ABT | Abbott Laboratories | 182.00B | 1.39% | 11,619,834 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 162.05B | 0.94% | 4,953,802 | 29.74B |
| 13 | PFE | Pfizer Inc. | 140.61B | 0.53% | 38,355,183 | 63.32B |
| 14 | DHR | Danaher Corporation | 138.14B | 2.61% | 5,340,633 | 25.11B |
| 15 | CVS | CVS Health Corporation | 136.61B | -0.62% | 7,857,618 | 405.62B |
| 16 | SYK | Stryker Corporation | 129.09B | 1.97% | 2,070,034 | 25.27B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.75B | 0.76% | 10,318,187 | 48.48B |
| 18 | ISRG | Intuitive Surgical, Inc. | 126.06B | 5.73% | 5,121,010 | 11.03B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 121.57B | 0.34% | 1,631,005 | 12.22B |
| 20 | MDT | Medtronic plc | 107.81B | 1.21% | 5,420,891 | 36.36B |
| 21 | SNY | Sanofi | 106.37B | 1.50% | 2,955,042 | 54.60B |
| 22 | GSK | GSK plc | 103.92B | 1.23% | 5,503,301 | 43.29B |
| 23 | MCK | McKesson Corporation | 99.52B | 1.09% | 799,752 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 86.43B | 1.94% | 1,979,793 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 82.05B | 0.18% | 1,179,728 | 201.11B |
| 26 | CI | The Cigna Group | 76.98B | 0.50% | 1,313,522 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 67.88B | 1.70% | 650,985 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 67.64B | 2.85% | 20,044,682 | 20.61B |
| 29 | COR | Cencora, Inc. | 60.54B | 0.41% | 1,004,597 | 328.68B |
| 30 | ARGX | argenx SE | 56.19B | -3.20% | 269,274 | 5.32B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 56.04B | 1.16% | 3,887,739 | 28.34B |
| 32 | CAH | Cardinal Health, Inc. | 53.72B | 0.58% | 1,106,324 | 250.74B |
| 33 | MDLN | Medline Inc. | 52.15B | 2.45% | 4,316,757 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 47.81B | 0.50% | 6,707,520 | 6.51B |
| 35 | HUM | Humana Inc. | 45.76B | -2.10% | 1,361,923 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 43.87B | 2.18% | 512,647 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 43.79B | 1.64% | 1,341,832 | 22.23B |
| 38 | HLN | Haleon plc | 43.39B | 1.64% | 22,565,513 | 14.85B |
| 39 | RVMD | Revolution Medicines, Inc. | 39.98B | -0.61% | 1,426,021 | - |
| 40 | A | Agilent Technologies, Inc. | 38.94B | -0.49% | 1,830,516 | 7.23B |
| 41 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.17B | 2.44% | 1,409,632 | 4.29B |
| 42 | NTRA | Natera, Inc. | 36.95B | -1.51% | 977,943 | 2.50B |
| 43 | WAT | Waters Corporation | 36.45B | -0.93% | 803,760 | 3.77B |
| 44 | ONC | BeOne Medicines AG | 36.23B | - | 302,476 | 5.74B |
| 45 | TEVA | Teva Pharmaceutical Industries Limited | 36.19B | 0.88% | 5,305,669 | 17.35B |
| 46 | IQV | IQVIA Holdings Inc. | 35.59B | 2.48% | 2,160,161 | 16.63B |
| 47 | RPRX | Royalty Pharma plc | 33.82B | -0.17% | 1,524,177 | 2.44B |
| 48 | ALC | Alcon Inc. | 33.18B | -0.93% | 2,875,607 | 10.63B |
| 49 | ZTS | Zoetis Inc. | 32.25B | 2.08% | 3,472,225 | 9.53B |
| 50 | CNC | Centene Corporation | 31.64B | 1.06% | 6,876,187 | 194.34B |
| 51 | VEEV | Veeva Systems Inc. | 31.59B | 4.41% | 1,708,891 | 3.32B |
| 52 | BIIB | Biogen Inc. | 29.55B | -1.01% | 762,582 | 9.94B |
| 53 | RMD | ResMed Inc. | 29.29B | 4.00% | 1,142,771 | 5.54B |
| 54 | ILMN | Illumina, Inc. | 28.67B | -2.38% | 1,738,895 | 4.39B |
| 55 | DXCM | DexCom, Inc. | 28.31B | 2.56% | 5,003,902 | 4.82B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 27.80B | 0.89% | 6,052,805 | 20.98B |
| 57 | MTD | Mettler-Toledo International Inc. | 27.00B | 0.69% | 110,398 | 4.09B |
| 58 | PHG | Koninklijke Philips N.V. | 26.00B | -4.39% | 6,323,356 | 20.18B |
| 59 | DGX | Quest Diagnostics Incorporated | 25.59B | 1.75% | 1,143,249 | 11.56B |
| 60 | ROIV | Roivant Sciences Ltd. | 24.97B | -0.83% | 4,272,715 | 8.26M |
| 61 | LH | Labcorp Holdings Inc. | 24.70B | 1.48% | 655,435 | 14.14B |
| 62 | INCY | Incyte Corporation | 23.75B | 1.02% | 2,729,176 | 5.82B |
| 63 | WST | West Pharmaceutical Services, Inc. | 23.31B | 0.93% | 1,605,643 | 3.33B |
| 64 | BNTX | BioNTech SE | 23.04B | 1.97% | 687,342 | 3.23B |
| 65 | INSM | Insmed Incorporated | 22.70B | -2.05% | 1,899,714 | 819.56M |
| 66 | UTHR | United Therapeutics Corporation | 22.41B | -0.10% | 431,349 | 3.17B |
| 67 | MRNA | Moderna, Inc. | 22.07B | 2.89% | 5,040,424 | 2.23B |
| 68 | STE | STERIS plc | 21.28B | 2.02% | 715,487 | 5.94B |
| 69 | THC | Tenet Healthcare Corporation | 20.96B | 4.36% | 2,218,919 | 21.81B |
| 70 | VTRS | Viatris Inc. | 20.54B | 2.29% | 9,762,895 | 14.56B |
| 71 | GH | Guardant Health, Inc. | 19.29B | -1.26% | 1,292,966 | 1.08B |
| 72 | GMAB | Genmab A/S | 17.83B | -0.24% | 1,526,785 | 3.90B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.81B | 0.79% | 1,568,278 | 8.41B |
| 74 | NBIX | Neurocrine Biosciences, Inc. | 17.74B | 0.36% | 1,047,909 | 3.10B |
| 75 | ASND | Ascendis Pharma A/S | 16.71B | -0.17% | 365,408 | 998.25M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.49B | 0.12% | 2,186,801 | 579.96M |
| 77 | MEDP | Medpace Holdings, Inc. | 16.45B | -2.00% | 415,466 | 2.78B |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 16.05B | 0.61% | 771,878 | 4.44B |
| 79 | DVA | DaVita Inc. | 15.17B | 0.37% | 625,467 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 15.00B | -1.28% | 1,962,435 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 14.03B | 0.79% | 2,316,907 | 2.38B |
| 82 | SOLV | Solventum Corporation | 13.94B | 3.15% | 1,045,402 | 8.26B |
| 83 | COO | The Cooper Companies, Inc. | 13.71B | -0.03% | 2,199,625 | 4.23B |
| 84 | FMS | Fresenius Medical Care AG | 13.24B | 1.14% | 453,252 | 22.32B |
| 85 | SNN | Smith & Nephew plc | 13.01B | 1.80% | 1,685,183 | 6.16B |
| 86 | ICLR | ICON Public Limited Company | 12.93B | 1.82% | 778,242 | 8.27B |
| 87 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.71B | 1.24% | 268,616 | 1.13B |
| 88 | ELAN | Elanco Animal Health Incorporated | 12.69B | 2.01% | 2,709,513 | 4.89B |
| 89 | PEN | Penumbra, Inc. | 12.57B | 0.24% | 338,837 | 1.45B |
| 90 | AXSM | Axsome Therapeutics, Inc. | 12.27B | -1.09% | 773,054 | 708.24M |
| 91 | RVTY | Revvity, Inc. | 12.06B | -2.17% | 1,349,053 | 2.90B |
| 92 | BAX | Baxter International Inc. | 12.05B | 4.20% | 5,445,303 | 11.32B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.05B | -0.08% | 2,444,316 | 622.01M |
| 94 | ALGN | Align Technology, Inc. | 12.04B | 0.62% | 1,032,779 | 4.10B |
| 95 | BMRN | BioMarin Pharmaceutical Inc. | 11.65B | 1.58% | 1,626,844 | 3.24B |
| 96 | PODD | Insulet Corporation | 11.43B | 1.07% | 1,115,279 | 2.90B |
| 97 | EHC | Encompass Health Corporation | 11.30B | 0.88% | 418,815 | 6.07B |
| 98 | TECH | Bio-Techne Corporation | 11.16B | 0.03% | 3,796,424 | 1.21B |
| 99 | ABVX | ABIVAX Société Anonyme | 11.10B | 1.83% | 662,347 | 5.67M |
| 100 | CYTK | Cytokinetics, Incorporated | 10.95B | -0.15% | 1,835,105 | 105.82M |
| 101 | CRL | Charles River Laboratories International, Inc. | 10.80B | -1.01% | 720,345 | 4.03B |
| 102 | GMED | Globus Medical, Inc. | 10.62B | 2.30% | 1,401,011 | 3.10B |
| 103 | SMMT | Summit Therapeutics Inc. | 10.45B | -4.06% | 4,234,218 | - |
| 104 | MOH | Molina Healthcare, Inc. | 10.39B | 0.98% | 1,153,445 | 42.47B |
| 105 | KRYS | Krystal Biotech, Inc. | 10.37B | 4.96% | 537,301 | 417.30M |
| 106 | ENSG | The Ensign Group, Inc. | 10.29B | 2.94% | 766,468 | 5.49B |
| 107 | APGE | Apogee Therapeutics, Inc. | 10.08B | - | 920,072 | - |
| 108 | RDY | Dr. Reddy's Laboratories Limited | 10.00B | -0.17% | 3,620,709 | 3.50B |
| 109 | CORT | Corcept Therapeutics Incorporated | 9.78B | -4.45% | 1,418,901 | 769.10M |
| 110 | HALO | Halozyme Therapeutics, Inc. | 9.66B | -0.55% | 1,435,892 | 1.51B |
| 111 | UHS | Universal Health Services, Inc. | 9.64B | 2.29% | 1,657,529 | 18.11B |
| 112 | HSIC | Henry Schein, Inc. | 9.64B | -1.01% | 1,494,991 | 13.38B |
| 113 | IONS | Ionis Pharmaceuticals, Inc. | 9.25B | -1.04% | 2,584,895 | 1.06B |
| 114 | BRKR | Bruker Corporation | 9.14B | -0.66% | 1,841,184 | 3.46B |
| 115 | KYMR | Kymera Therapeutics, Inc. | 9.05B | -0.47% | 474,166 | 51.48M |
| 116 | GKOS | Glaukos Corporation | 8.92B | -1.09% | 727,533 | 551.35M |
| 117 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.84B | 0.14% | 5,216,888 | 18.07M |
| 118 | PRAX | Praxis Precision Medicines, Inc. | 8.80B | -2.92% | 296,061 | 7.46M |
| 119 | SYRE | Spyre Therapeutics, Inc. | 8.80B | -2.05% | 669,886 | - |
| 120 | ALKS | Alkermes plc | 8.79B | -0.30% | 1,402,922 | 1.67B |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 8.72B | -0.40% | 416,781 | 74.06M |
| 122 | OSCR | Oscar Health, Inc. | 8.54B | 0.53% | 3,496,950 | 13.30B |
| 123 | ATR | AptarGroup, Inc. | 8.51B | 0.76% | 411,235 | 3.87B |
| 124 | QGEN | Qiagen N.V. | 8.50B | -0.70% | 1,651,529 | 2.10B |
| 125 | BIO | Bio-Rad Laboratories, Inc. | 8.47B | 0.62% | 348,909 | 2.59B |
| 126 | HQY | HealthEquity, Inc. | 8.28B | 4.66% | 702,991 | 1.34B |
| 127 | IMVT | Immunovant, Inc. | 8.27B | 1.73% | 930,538 | - |
| 128 | AVTR | Avantor, Inc. | 8.03B | 2.80% | 16,504,929 | 6.55B |
| 129 | PCVX | Vaxcyte, Inc. | 8.01B | 1.54% | 1,009,792 | - |
| 130 | TGTX | TG Therapeutics, Inc. | 7.90B | -0.52% | 1,680,374 | 700.35M |
| 131 | TEM | Tempus AI, Inc. | 7.73B | 0.52% | 5,403,524 | 1.36B |
| 132 | LQDA | Liquidia Corporation | 7.51B | -2.09% | 1,447,057 | 288.07M |
| 133 | PACS | PACS Group, Inc. | 7.45B | 0.49% | 967,694 | 5.43B |
| 134 | RGEN | Repligen Corporation | 7.40B | -0.68% | 1,456,918 | 763.34M |
| 135 | IBRX | ImmunityBio, Inc. | 7.32B | -1.55% | 10,517,949 | 140.98M |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.27B | 3.95% | 727,724 | 217.17M |
| 137 | LNTH | Lantheus Holdings, Inc. | 7.03B | 3.06% | 1,098,512 | 1.55B |
| 138 | HIMS | Hims & Hers Health, Inc. | 7.00B | 7.65% | 16,175,404 | 2.37B |
| 139 | MIRM | Mirum Pharmaceuticals, Inc. | 6.96B | 1.04% | 431,344 | 569.61M |
| 140 | COGT | Cogent Biosciences, Inc. | 6.91B | 1.71% | 1,383,712 | - |
| 141 | GRFS | Grifols, S.A. | 6.74B | 2.24% | 388,954 | 8.58B |
| 142 | CHE | Chemed Corporation | 6.73B | -0.35% | 163,761 | 2.54B |
| 143 | ERAS | Erasca, Inc. | 6.55B | -1.26% | 3,531,885 | - |
| 144 | CGON | CG Oncology, Inc. | 6.48B | 6.06% | 1,140,634 | 5.07M |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 6.36B | 0.55% | 517,186 | 7.50M |
| 146 | PTCT | PTC Therapeutics, Inc. | 6.29B | -1.33% | 1,852,689 | 827.11M |
| 147 | BLTE | Belite Bio, Inc | 6.23B | 3.31% | 136,539 | - |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 5.89B | -1.01% | 378,443 | 274.48M |
| 149 | BLLN | BillionToOne, Inc. | 5.89B | 1.51% | 480,074 | 354.54M |
| 150 | SRRK | Scholar Rock Holding Corporation | 5.86B | 2.64% | 1,250,493 | - |
| 151 | TXG | 10x Genomics, Inc. | 5.83B | -0.76% | 2,109,133 | 638.78M |
| 152 | HNGE | Hinge Health, Inc. | 5.81B | 1.08% | 951,321 | 646.34M |
| 153 | BLCO | Bausch + Lomb Corporation | 5.80B | 0.68% | 696,898 | 5.21B |
| 154 | TFX | Teleflex Incorporated | 5.80B | -0.79% | 432,587 | 2.13B |
| 155 | AMRX | Amneal Pharmaceuticals, Inc. | 5.77B | 0.95% | 1,190,673 | 3.05B |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 5.71B | 0.60% | 609,983 | 1.34M |
| 157 | DFTX | Definium Therapeutics, Inc. | 5.66B | -1.20% | 1,556,508 | - |
| 158 | ORKA | Oruka Therapeutics, Inc. | 5.44B | -2.13% | 744,539 | - |
| 159 | STVN | Stevanato Group S.p.A. | 5.41B | 0.61% | 353,732 | 1.39B |
| 160 | TWST | Twist Bioscience Corporation | 5.39B | -4.13% | 1,347,517 | 409.48M |
| 161 | TVTX | Travere Therapeutics, Inc. | 5.27B | -1.19% | 1,663,214 | 536.20M |
| 162 | MMED | MiniMed Group, Inc. | 4.96B | 4.99% | 1,915,702 | 3.10B |
| 163 | SHC | Sotera Health Company | 4.92B | -0.63% | 2,344,471 | 1.19B |
| 164 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.89B | 1.11% | 834,534 | 840.85M |
| 165 | INDV | Indivior Pharmaceuticals, Inc. | 4.88B | -1.23% | 998,380 | 1.29B |
| 166 | RDNT | RadNet, Inc. | 4.84B | -0.10% | 476,742 | 2.14B |
| 167 | DYN | Dyne Therapeutics, Inc. | 4.78B | 4.87% | 3,332,444 | - |
| 168 | MANE | Veradermics, Incorporated | 4.65B | 1.74% | 554,189 | - |
| 169 | CRSP | CRISPR Therapeutics AG | 4.60B | 0.41% | 1,335,138 | 4.10M |
| 170 | MMSI | Merit Medical Systems, Inc. | 4.54B | 2.40% | 1,025,047 | 1.54B |
| 171 | EWTX | Edgewise Therapeutics, Inc. | 4.48B | 1.86% | 1,068,780 | - |
| 172 | VCYT | Veracyte, Inc. | 4.44B | -1.77% | 748,902 | 541.74M |
| 173 | WAY | Waystar Holding Corp. | 4.44B | 2.73% | 2,143,757 | 1.16B |
| 174 | LIVN | LivaNova PLC | 4.43B | 3.06% | 486,532 | 1.43B |
| 175 | CAI | Caris Life Sciences, Inc. | 4.42B | 0.71% | 3,454,755 | 907.29M |
| 176 | ACAD | ACADIA Pharmaceuticals Inc. | 4.35B | 2.21% | 1,399,666 | 1.10B |
| 177 | NVST | Envista Holdings Corporation | 4.34B | 1.18% | 2,041,506 | 2.81B |
| 178 | LFST | LifeStance Health Group, Inc. | 4.22B | -0.18% | 1,910,595 | 1.49B |
| 179 | CON | Concentra Group Holdings Parent, Inc. | 4.08B | 0.89% | 519,369 | 2.23B |
| 180 | RLAY | Relay Therapeutics, Inc. | 4.06B | 1.08% | 4,202,088 | 10.68M |
| 181 | PBLS | Parabilis Medicines, Inc. | 4.05B | 1.73% | 222,287 | - |
| 182 | VKTX | Viking Therapeutics, Inc. | 4.05B | 0.23% | 1,890,124 | - |
| 183 | ICUI | ICU Medical, Inc. | 4.04B | 2.55% | 363,589 | 2.16B |
| 184 | CELC | Celcuity Inc. | 4.01B | -0.42% | 1,763,277 | - |
| 185 | TNGX | Tango Therapeutics, Inc. | 3.86B | 0.34% | 2,199,402 | 56.99M |
| 186 | ALHC | Alignment Healthcare, Inc. | 3.86B | -3.91% | 3,950,640 | 4.26B |
| 187 | DOCS | Doximity, Inc. | 3.77B | 2.79% | 4,573,380 | 644.86M |
| 188 | DNLI | Denali Therapeutics Inc. | 3.74B | 1.99% | 1,747,217 | - |
| 189 | LEGN | Legend Biotech Corporation | 3.73B | -13.28% | 10,070,935 | 1.14B |
| 190 | BKD | Brookdale Senior Living Inc. | 3.69B | 2.11% | 7,924,772 | 3.00B |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.69B | 2.70% | 427,510 | 787.85M |
| 192 | ELVN | Enliven Therapeutics, Inc. | 3.68B | -0.41% | 1,408,412 | - |
| 193 | HAE | Haemonetics Corporation | 3.63B | 1.43% | 803,182 | 1.33B |
| 194 | ADPT | Adaptive Biotechnologies Corporation | 3.61B | 1.21% | 2,437,488 | 295.41M |
| 195 | OGN | Organon & Co. | 3.56B | 0.15% | 2,654,587 | 6.16B |
| 196 | NAMS | NewAmsterdam Pharma Company N.V. | 3.53B | 1.96% | 948,742 | 22.57M |
| 197 | NHC | National HealthCare Corporation | 3.53B | 0.18% | 102,919 | 1.53B |
| 198 | RCUS | Arcus Biosciences, Inc. | 3.50B | -2.04% | 1,268,818 | 236.00M |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.50B | 3.87% | 1,172,729 | 225.27M |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.48B | 1.79% | 1,199,084 | 415.62M |
| 201 | GPCR | Structure Therapeutics Inc. | 3.46B | -0.88% | 464,407 | - |
| 202 | ALMS | Alumis Inc. | 3.45B | -3.29% | 1,049,712 | 8.40M |
| 203 | TLX | Telix Pharmaceuticals Limited | 3.44B | -2.35% | 106,273 | 803.79M |
| 204 | OPCH | Option Care Health, Inc. | 3.42B | 0.69% | 2,216,157 | 5.67B |
| 205 | ITGR | Integer Holdings Corporation | 3.38B | 0.79% | 651,369 | 1.86B |
| 206 | PRVA | Privia Health Group, Inc. | 3.11B | -3.25% | 810,819 | 2.25B |
| 207 | WRBY | Warby Parker Inc. | 3.05B | 1.22% | 2,028,417 | 890.57M |
| 208 | ACHC | Acadia Healthcare Company, Inc. | 2.99B | -5.82% | 4,982,946 | 3.37B |
| 209 | MBX | MBX Biosciences, Inc. | 2.92B | -1.13% | 304,265 | - |
| 210 | RGC | Regencell Bioscience Holdings Limited | 2.89B | 1.92% | 202,329 | - |
| 211 | GRAL | GRAIL, Inc. | 2.87B | -1.58% | 441,439 | 156.12M |
| 212 | IRON | Disc Medicine, Inc. | 2.85B | 0.66% | 355,429 | - |
| 213 | CLDX | Celldex Therapeutics, Inc. | 2.80B | 1.05% | 1,040,865 | 865.00K |
| 214 | SUPN | Supernus Pharmaceuticals, Inc. | 2.73B | 1.69% | 523,013 | 776.83M |
| 215 | ESTA | Establishment Labs Holdings Inc. | 2.71B | -0.24% | 377,215 | 229.58M |
| 216 | ATAI | AtaiBeckley Inc. | 2.65B | -0.14% | 9,634,492 | 3.49M |
| 217 | RARE | Ultragenyx Pharmaceutical Inc. | 2.64B | -0.04% | 1,766,761 | 670.00M |
| 218 | QURE | uniQure N.V. | 2.63B | -1.95% | 1,475,411 | 18.09M |
| 219 | GRDN | Guardian Pharmacy Services, Inc. | 2.63B | 2.50% | 315,810 | 1.46B |
| 220 | KOD | Kodiak Sciences Inc. | 2.62B | 1.21% | 464,832 | - |
| 221 | XRAY | DENTSPLY SIRONA Inc. | 2.61B | 0.70% | 4,061,124 | 3.68B |
| 222 | TARS | Tarsus Pharmaceuticals, Inc. | 2.59B | 2.49% | 725,405 | 535.08M |
| 223 | TRVI | Trevi Therapeutics, Inc. | 2.57B | 3.31% | 1,762,192 | - |
| 224 | TMDX | TransMedics Group, Inc. | 2.57B | 2.80% | 644,245 | 635.89M |
| 225 | IMNM | Immunome, Inc. | 2.56B | 1.67% | 850,511 | 4.02M |
| 226 | VERA | Vera Therapeutics, Inc. | 2.53B | -0.76% | 1,110,158 | - |
| 227 | BEAM | Beam Therapeutics Inc. | 2.50B | -0.12% | 1,819,481 | 164.01M |
| 228 | PGNY | Progyny, Inc. | 2.47B | 1.28% | 994,733 | 1.29B |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.43B | 2.57% | 4,310,712 | 885.72M |
| 230 | NRIX | Nurix Therapeutics, Inc. | 2.43B | 0.21% | 1,282,828 | 36.77M |
| 231 | NKTR | Nektar Therapeutics | 2.41B | 0.88% | 818,038 | 55.63M |
| 232 | MLYS | Mineralys Therapeutics, Inc. | 2.40B | 1.87% | 830,700 | - |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.39B | 1.49% | 435,844 | 1.09B |
| 234 | PHVS | Pharvaris N.V. | 2.37B | -0.59% | 213,202 | - |
| 235 | COAG | Hemab Therapeutics Holdings, Inc. | 2.35B | 6.51% | 386,322 | - |
| 236 | NUVB | Nuvation Bio Inc. | 2.32B | 3.74% | 6,027,012 | 143.05M |
| 237 | VCEL | Vericel Corporation | 2.31B | 0.60% | 394,660 | 292.09M |
| 238 | PLSE | Pulse Biosciences, Inc. | 2.27B | 8.47% | 432,453 | 751.00K |
| 239 | KLRA | Kailera Therapeutics, Inc. | 2.26B | -1.19% | 567,852 | - |
| 240 | LMAT | LeMaitre Vascular, Inc. | 2.26B | 3.49% | 285,129 | 256.28M |
| 241 | CLOV | Clover Health Investments, Corp. | 2.25B | -1.16% | 3,496,971 | 2.21B |
| 242 | AGIO | Agios Pharmaceuticals, Inc. | 2.20B | 1.68% | 992,590 | 66.05M |
| 243 | HTFL | HeartFlow, Inc. | 2.19B | 5.18% | 1,640,779 | 191.42M |
| 244 | IOVA | Iovance Biotherapeutics, Inc. | 2.19B | -1.80% | 13,245,332 | 285.61M |
| 245 | AXGN | Axogen, Inc. | 2.19B | 4.18% | 971,235 | 238.11M |
| 246 | BHVN | Biohaven Ltd. | 2.18B | 1.33% | 1,875,511 | - |
| 247 | VRDN | Viridian Therapeutics, Inc. | 2.18B | 2.23% | 2,224,646 | 70.92M |
| 248 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.17B | 5.87% | 2,581,117 | -665.00K |
| 249 | SLS | SELLAS Life Sciences Group, Inc. | 2.13B | -4.28% | 9,157,607 | - |
| 250 | ADUS | Addus HomeCare Corporation | 2.11B | 0.96% | 170,017 | 1.45B |
| 251 | AVAH | Aveanna Healthcare Holdings Inc. | 2.11B | 2.33% | 1,958,448 | 2.52B |
| 252 | MD | Pediatrix Medical Group, Inc. | 2.10B | -0.46% | 754,705 | 1.93B |
| 253 | ZLAB | Zai Lab Limited | 2.09B | -3.02% | 708,637 | 453.28M |
| 254 | HRMY | Harmony Biosciences Holdings, Inc. | 2.08B | 1.95% | 623,903 | 899.11M |
| 255 | ZBIO | Zenas BioPharma, Inc. | 2.07B | 8.00% | 1,153,947 | 10.00M |
| 256 | SION | Sionna Therapeutics, Inc. | 2.05B | -0.70% | 403,811 | - |
| 257 | PVLA | Palvella Therapeutics, Inc. | 2.03B | 2.72% | 173,587 | - |
| 258 | NEOG | Neogen Corporation | 2.03B | -0.64% | 2,413,448 | 870.56M |
| 259 | NBTX | Nanobiotix S.A. | 2.03B | 1.21% | 95,215 | 38.27M |
| 260 | URGN | UroGen Pharma Ltd. | 2.02B | 1.20% | 517,132 | 140.49M |
| 261 | RAPP | Rapport Therapeutics, Inc. | 2.01B | 3.55% | 312,698 | 20.00M |
| 262 | SNDA | Sonida Senior Living, Inc. | 2.00B | 2.71% | 772,477 | 367.34M |
| 263 | NVCR | NovoCure Limited | 1.98B | -3.51% | 1,811,940 | 699.19M |
| 264 | SGRY | Surgery Partners, Inc. | 1.97B | -3.56% | 1,614,899 | 3.34B |
| 265 | ADMA | ADMA Biologics, Inc. | 1.97B | 2.54% | 2,388,882 | 509.86M |
| 266 | AUPH | Aurinia Pharmaceuticals Inc. | 1.96B | -0.85% | 1,056,644 | 298.30M |
| 267 | HCM | HUTCHMED (China) Limited | 1.93B | 1.00% | 40,122 | 548.51M |
| 268 | PGEN | Precigen, Inc. | 1.93B | 0.37% | 5,534,326 | 31.60M |
| 269 | UFPT | UFP Technologies, Inc. | 1.92B | 4.82% | 241,860 | 608.85M |
| 270 | GLUE | Monte Rosa Therapeutics, Inc. | 1.91B | -0.97% | 1,099,815 | 42.95M |
| 271 | GHRS | GH Research PLC | 1.90B | 1.72% | 279,933 | - |
| 272 | KARD | Kardigan, Inc. | 1.90B | 2.36% | 141,391 | - |
| 273 | ATRC | AtriCure, Inc. | 1.89B | 6.65% | 1,189,290 | 569.62M |
| 274 | OCUL | Ocular Therapeutix, Inc. | 1.89B | 1.53% | 1,539,831 | 52.04M |
| 275 | OMCL | Omnicell, Inc. | 1.89B | 1.20% | 838,424 | 1.23B |
| 276 | CDNA | CareDx, Inc. | 1.88B | -2.10% | 604,619 | 412.82M |
| 277 | MESO | Mesoblast Limited | 1.87B | -4.90% | 325,399 | 65.38M |
| 278 | FBRX | Forte Biosciences, Inc. | 1.87B | 39.65% | 17,545,448 | - |
| 279 | LKFT | Lakefront Biotherapeutics NV | 1.86B | 1.04% | 109,049 | 1.20B |
| 280 | BFLY | Butterfly Network, Inc. | 1.85B | 7.45% | 4,952,679 | 102.92M |
| 281 | TYRA | Tyra Biosciences, Inc. | 1.85B | 1.40% | 473,786 | - |
| 282 | BCAX | Bicara Therapeutics Inc. | 1.83B | 2.92% | 499,476 | - |
| 283 | STOK | Stoke Therapeutics, Inc. | 1.83B | 0.03% | 594,611 | 32.08M |
| 284 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | -1.39% | 1,098,247 | 217.17M |
| 285 | FTRE | Fortrea Holdings Inc. | 1.82B | -1.64% | 1,433,219 | 2.71B |
| 286 | DMRA | Damora Therapeutics, Inc. | 1.81B | 2.15% | 547,180 | - |
| 287 | WGS | GeneDx Holdings Corp. | 1.80B | 2.44% | 611,524 | 442.68M |
| 288 | TSHA | Taysha Gene Therapies, Inc. | 1.77B | 0.36% | 2,367,119 | 7.47M |
| 289 | GENB | Generate Biomedicines, Inc. | 1.75B | 2.09% | 290,390 | 30.30M |
| 290 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.73B | -1.04% | 2,195,144 | 204.73M |
| 291 | ASTH | Astrana Health, Inc. | 1.72B | -5.26% | 598,738 | 3.53B |
| 292 | IMCR | Immunocore Holdings plc | 1.72B | -3.51% | 329,132 | 412.81M |
| 293 | NEO | NeoGenomics, Inc. | 1.71B | -5.40% | 1,795,795 | 745.97M |
| 294 | ALMR | Alamar Biosciences, Inc. | 1.69B | -5.72% | 179,205 | 87.16M |
| 295 | SRPT | Sarepta Therapeutics, Inc. | 1.68B | 1.34% | 3,701,422 | 2.18B |
| 296 | BHC | Bausch Health Companies Inc. | 1.67B | 1.13% | 1,715,287 | 10.53B |
| 297 | ANIP | ANI Pharmaceuticals, Inc. | 1.66B | 0.93% | 352,409 | 923.71M |
| 298 | AAPG | Ascentage Pharma Group International | 1.65B | 3.28% | 2,017 | 82.08M |
| 299 | ZYME | Zymeworks Inc. | 1.65B | 0.61% | 259,301 | 81.26M |
| 300 | MLTX | MoonLake Immunotherapeutics | 1.64B | 4.52% | 879,409 | - |
| 301 | AGL | agilon health, inc. | 1.64B | 0.44% | 384,775 | 5.82B |
| 302 | ENOV | Enovis Corporation | 1.63B | 4.51% | 827,686 | 2.28B |
| 303 | TDOC | Teladoc Health, Inc. | 1.61B | 1.60% | 3,342,586 | 2.51B |
| 304 | ABCL | AbCellera Biologics Inc. | 1.60B | -1.13% | 4,230,206 | 79.21M |
| 305 | TRLV | Trulieve Cannabis Corp. | 1.60B | -0.36% | 888,706 | 1.17B |
| 306 | RXRX | Recursion Pharmaceuticals, Inc. | 1.60B | 1.69% | 21,724,275 | 66.41M |
| 307 | MAZE | Maze Therapeutics, Inc. | 1.59B | 3.65% | 269,883 | 20.00M |
| 308 | ANAB | AnaptysBio, Inc. | 1.59B | -1.00% | 386,107 | 232.39M |
| 309 | HCSG | Healthcare Services Group, Inc. | 1.58B | 0.92% | 716,898 | 1.86B |
| 310 | INVA | Innoviva, Inc. | 1.57B | -0.65% | 624,275 | 420.69M |
| 311 | ARDT | Ardent Health, Inc. | 1.57B | 2.91% | 648,846 | 6.43B |
| 312 | INNV | InnovAge Holding Corp. | 1.56B | -0.69% | 236,599 | 949.17M |
| 313 | CMPS | COMPASS Pathways plc | 1.52B | 0.09% | 2,983,858 | - |
| 314 | IART | Integra LifeSciences Holdings Corporation | 1.52B | -1.31% | 1,015,193 | 1.64B |
| 315 | SEPN | Septerna, Inc. | 1.51B | 1.18% | 143,877 | 72.26M |
| 316 | NTLA | Intellia Therapeutics, Inc. | 1.49B | -0.56% | 2,892,763 | 66.09M |
| 317 | XERS | Xeris Biopharma Holdings, Inc. | 1.49B | -1.32% | 873,434 | 314.85M |
| 318 | VIR | Vir Biotechnology, Inc. | 1.48B | 1.27% | 1,687,973 | 65.50M |
| 319 | XNCR | Xencor, Inc. | 1.47B | 2.16% | 942,303 | 97.36M |
| 320 | INSP | Inspire Medical Systems, Inc. | 1.47B | 3.54% | 944,844 | 915.25M |
| 321 | TRAX | First Tracks Biotherapeutics, Inc. | 1.47B | 18.33% | 2,592,086 | - |
| 322 | AHCO | AdaptHealth Corp. | 1.46B | 1.86% | 967,288 | 3.29B |
| 323 | BLFS | BioLife Solutions, Inc. | 1.46B | -0.63% | 1,060,248 | 101.66M |
| 324 | PNTG | The Pennant Group, Inc. | 1.44B | 0.44% | 156,857 | 1.02B |
| 325 | PAHC | Phibro Animal Health Corporation | 1.43B | 3.53% | 144,188 | 1.50B |
| 326 | AVBP | ArriVent BioPharma, Inc. | 1.40B | -4.95% | 759,265 | - |
| 327 | PRGO | Perrigo Company plc | 1.40B | 0.50% | 3,139,025 | 4.18B |
| 328 | HROW | Harrow, Inc. | 1.40B | -2.57% | 516,682 | 268.68M |
| 329 | SVRA | Savara Inc. | 1.38B | -1.45% | 3,791,798 | - |
| 330 | AKTS | Aktis Oncology, Inc. | 1.34B | 1.34% | 258,787 | 8.28M |
| 331 | KMTS | Kestra Medical Technologies, Ltd. | 1.34B | 8.36% | 195,807 | 95.13M |
| 332 | ATEC | Alphatec Holdings, Inc. | 1.33B | 4.96% | 1,789,818 | 787.08M |
| 333 | CNMD | CONMED Corporation | 1.31B | 1.94% | 437,719 | 1.37B |
| 334 | AMN | AMN Healthcare Services, Inc. | 1.30B | 1.70% | 505,787 | 3.42B |
| 335 | FRNM | Freenome, Inc. | 1.28B | 1.25% | 1,449,225 | 34.24M |
| 336 | ABSI | Absci Corporation | 1.28B | - | 2,452,721 | 1.84M |
| 337 | AZTA | Azenta, Inc. | 1.27B | 0.55% | 710,667 | 596.48M |
| 338 | AORT | Artivion, Inc. | 1.27B | 3.24% | 427,599 | 458.69M |
| 339 | PSNL | Personalis, Inc. | 1.25B | 1.70% | 4,618,079 | 64.52M |
| 340 | AHG | Akso Health Group | 1.25B | -3.31% | 19,393 | 13.83M |
| 341 | ARDX | Ardelyx, Inc. | 1.25B | 0.60% | 1,811,016 | 427.68M |
| 342 | ORIC | ORIC Pharmaceuticals, Inc. | 1.24B | -0.66% | 1,707,651 | - |
| 343 | NVAX | Novavax, Inc. | 1.23B | 0.40% | 3,318,593 | 596.34M |
| 344 | AVLN | Avalyn Pharma Inc. | 1.22B | -1.18% | 193,542 | - |
| 345 | OMDA | Omada Health, Inc. | 1.22B | 0.24% | 1,967,862 | 283.30M |
| 346 | MNKD | MannKind Corporation | 1.22B | -4.36% | 5,325,677 | 360.78M |
| 347 | IRMD | IRADIMED CORPORATION | 1.22B | 0.62% | 67,185 | 86.28M |
| 348 | INBX | Inhibrx Biosciences, Inc. | 1.21B | 1.10% | 266,031 | 1.30M |
| 349 | CERT | Certara, Inc. | 1.21B | 3.20% | 4,263,619 | 419.75M |
| 350 | JBIO | Jade Biosciences, Inc. | 1.18B | -0.65% | 1,415,747 | - |
| 351 | IMTX | Immatics N.V. | 1.18B | -4.96% | 453,193 | 43.00M |
| 352 | TNDM | Tandem Diabetes Care, Inc. | 1.18B | 0.29% | 1,577,418 | 1.03B |
| 353 | USPH | U.S. Physical Therapy, Inc. | 1.17B | 2.76% | 156,674 | 787.69M |
| 354 | ETON | Eton Pharmaceuticals, Inc. | 1.16B | -0.66% | 365,383 | 86.93M |
| 355 | COLL | Collegium Pharmaceutical, Inc. | 1.15B | 0.91% | 309,712 | 796.33M |
| 356 | QDEL | QuidelOrtho Corporation | 1.15B | 4.86% | 1,057,030 | 2.66B |
| 357 | STAA | STAAR Surgical Company | 1.14B | -1.84% | 725,123 | 290.38M |
| 358 | SDGR | Schrödinger, Inc. | 1.14B | 2.07% | 643,404 | 254.91M |
| 359 | MGTX | MeiraGTx Holdings plc | 1.14B | 4.50% | 585,799 | 79.76M |
| 360 | WVE | Wave Life Sciences Ltd. | 1.14B | 1.89% | 1,927,679 | 71.80M |
| 361 | DRTS | Alpha Tau Medical Ltd. | 1.10B | -2.32% | 503,966 | - |
| 362 | SPTX | Seaport Therapeutics, Inc. | 1.10B | -2.65% | 117,653 | - |
| 363 | ALVO | Alvotech | 1.10B | 0.65% | 397,899 | 562.04M |
| 364 | CRVS | Corvus Pharmaceuticals, Inc. | 1.09B | -1.15% | 846,901 | - |
| 365 | ANRO | Alto Neuroscience, Inc. | 1.08B | 4.07% | 499,762 | - |
| 366 | CRON | Cronos Group Inc. | 1.08B | 1.78% | 1,065,130 | 159.54M |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 1.07B | 1.93% | 530,606 | - |
| 368 | LMRI | Lumexa Imaging Holdings, Inc. | 1.06B | 1.10% | 243,738 | 1.03B |
| 369 | IVA | Inventiva S.A. | 1.05B | 3.14% | 707,171 | 7.94M |
| 370 | VOR | Vor Biopharma Inc. | 1.05B | 0.93% | 948,246 | - |
| 371 | OLMA | Olema Pharmaceuticals, Inc. | 1.05B | 2.65% | 1,128,954 | - |
| 372 | PCRX | Pacira BioSciences, Inc. | 1.04B | 2.28% | 553,346 | 734.86M |
| 373 | EYPT | EyePoint, Inc. | 1.04B | 1.80% | 1,390,307 | 7.61M |
| 374 | BVS | Bioventus Inc. | 1.04B | 5.51% | 823,019 | 576.30M |
| 375 | GDRX | GoodRx Holdings, Inc. | 1.03B | 3.04% | 1,060,117 | 787.89M |
| 376 | AVTX | Avalo Therapeutics, Inc. | 1.03B | 5.75% | 1,168,714 | 59.00K |
| 377 | NUTX | Nutex Health Inc. | 1.02B | 1.94% | 105,969 | 879.95M |
| 378 | PRCT | PROCEPT BioRobotics Corporation | 1.01B | 5.99% | 1,344,446 | 322.02M |
| 379 | LBRX | LB Pharmaceuticals Inc | 997.37M | -0.66% | 217,913 | - |
| 380 | LXRX | Lexicon Pharmaceuticals, Inc. | 990.56M | -2.62% | 2,957,356 | 69.64M |
| 381 | GMRS | GMR Solutions Inc. | 988.49M | -1.93% | 204,172 | 5.83B |
| 382 | SANA | Sana Biotechnology, Inc. | 983.67M | 3.14% | 3,580,754 | - |
| 383 | JANX | Janux Therapeutics, Inc. | 949.53M | 1.57% | 1,395,288 | 13.73M |
| 384 | GERN | Geron Corporation | 949.45M | 4.23% | 8,915,739 | 196.12M |
| 385 | PHAT | Phathom Pharmaceuticals, Inc. | 949.19M | 4.46% | 664,730 | 204.89M |
| 386 | BIOA | BioAge Labs, Inc. | 928.17M | -4.09% | 497,350 | 10.32M |
| 387 | OPK | OPKO Health, Inc. | 925.45M | 1.64% | 4,349,942 | 587.90M |
| 388 | ODTX | Odyssey Therapeutics, Inc. | 911.12M | 1.98% | 159,413 | 1.06M |
| 389 | PHAR | Pharming Group N.V. | 907.82M | 3.11% | 5,737 | 369.49M |
| 390 | KURA | Kura Oncology, Inc. | 901.06M | -2.31% | 1,193,867 | 71.64M |
| 391 | INMD | InMode Ltd. | 884.05M | 1.38% | 688,606 | 374.64M |
| 392 | TALK | Talkspace, Inc. | 874.42M | 0.19% | 672,501 | 238.37M |
| 393 | TBPH | Theravance Biopharma, Inc. | 873.82M | - | 395,411 | 109.78M |
| 394 | ABUS | Arbutus Biopharma Corporation | 871.14M | 0.68% | 977,802 | 191.45M |
| 395 | GLAS | Glass House Brands Inc. | 860.96M | 1.00% | 191,928 | 177.68M |
| 396 | AMPH | Amphastar Pharmaceuticals, Inc. | 845.70M | 2.46% | 285,920 | 720.53M |
| 397 | ANNX | Annexon, Inc. | 840.51M | -1.72% | 1,634,975 | - |
| 398 | TENX | Tenax Therapeutics, Inc. | 827.18M | 11.42% | 1,803,993 | - |
| 399 | DBVT | DBV Technologies S.A. | 821.33M | 1.98% | 380,748 | 5.04M |
| 400 | OMER | Omeros Corporation | 820.74M | 15.83% | 3,360,609 | 9.89M |
| 401 | HSTM | HealthStream, Inc. | 814.23M | 2.69% | 173,389 | 311.78M |
| 402 | AVR | Anteris Technologies Global Corp. | 796.21M | 0.49% | 838,227 | 1.85M |
| 403 | SSII | SS Innovations International, Inc. | 792.52M | 13.96% | 239,579 | 48.47M |
| 404 | AURA | Aura Biosciences, Inc. | 789.74M | 1.56% | 252,141 | - |
| 405 | SLDB | Solid Biosciences Inc. | 776.77M | 0.77% | 1,222,962 | - |
| 406 | SIBN | SI-BONE, Inc. | 756.16M | 2.59% | 620,113 | 206.22M |
| 407 | FTH | Faeth Therapeutics, Inc. | 753.77M | 3.36% | 359,115 | - |
| 408 | ACRS | Aclaris Therapeutics, Inc. | 749.99M | 2.68% | 4,860,253 | 8.37M |
| 409 | DSGN | Design Therapeutics, Inc. | 741.99M | 0.85% | 323,092 | - |
| 410 | CSTL | Castle Biosciences, Inc. | 741.26M | -1.01% | 291,639 | 339.92M |
| 411 | MNPR | Monopar Therapeutics Inc. | 739.08M | 0.42% | 339,768 | - |
| 412 | CLYM | Climb Bio, Inc. | 732.36M | -0.39% | 1,210,820 | - |
| 413 | CADL | Candel Therapeutics, Inc. | 729.77M | 4.18% | 1,272,117 | - |
| 414 | REPL | Replimune Group, Inc. | 724.61M | -11.03% | 8,460,299 | - |
| 415 | BBNX | Beta Bionics, Inc. | 712.54M | 0.88% | 850,683 | 110.24M |
| 416 | CTMX | CytomX Therapeutics, Inc. | 707.53M | 0.31% | 2,501,754 | 35.54M |
| 417 | DRUG | Bright Minds Biosciences Inc. | 706.56M | 0.81% | 194,644 | - |
| 418 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 700.94M | -0.79% | 240,886 | - |
| 419 | CBIO | Crescent Biopharma, Inc. | 699.61M | 3.87% | 272,069 | 11.88M |
| 420 | SGP | SpyGlass Pharma, Inc. | 696.08M | 1.61% | 55,873 | - |
| 421 | EVO | Evotec SE | 692.31M | -1.03% | 106,394 | 859.03M |
| 422 | RIGL | Rigel Pharmaceuticals, Inc. | 691.79M | 1.77% | 229,598 | 299.77M |
| 423 | NGNE | Neurogene Inc. | 689.87M | -0.80% | 241,541 | 925.00K |
| 424 | CBLL | CeriBell, Inc. | 687.90M | 7.21% | 442,387 | 95.07M |
| 425 | GYRE | Gyre Therapeutics, Inc. | 683.43M | 3.20% | 43,079 | 117.05M |
| 426 | OCS | Oculis Holding AG | 665.48M | -0.99% | 379,542 | 1.40M |
| 427 | PHR | Phreesia, Inc. | 657.06M | 4.01% | 825,394 | 495.59M |
| 428 | BWAY | BrainsWay Ltd. | 647.30M | -1.31% | 224,014 | 56.22M |
| 429 | IRWD | Ironwood Pharmaceuticals, Inc. | 643.64M | 5.39% | 1,930,760 | 361.51M |
| 430 | MDXG | MiMedx Group, Inc. | 634.51M | 1.43% | 1,163,226 | 389.42M |
| 431 | ACHV | Achieve Life Sciences, Inc. | 634.43M | 1.31% | 954,644 | - |
| 432 | TCMD | Tactile Systems Technology, Inc. | 626.16M | 1.02% | 126,763 | 343.52M |
| 433 | IMMX | Immix Biopharma, Inc. | 618.64M | 2.00% | 1,990,297 | - |
| 434 | AGMB | AgomAb Therapeutics NV | 616.09M | - | 33,397 | - |
| 435 | NVCT | Nuvectis Pharma, Inc. | 616.01M | 1.19% | 146,607 | - |
| 436 | CERS | Cerus Corporation | 615.13M | 4.78% | 1,655,123 | 216.56M |
| 437 | ALLO | Allogene Therapeutics, Inc. | 604.02M | 0.57% | 6,901,348 | 22.00K |
| 438 | RGNX | REGENXBIO Inc. | 599.13M | -0.21% | 1,248,613 | 87.82M |
| 439 | CRMD | CorMedix Inc. | 596.23M | -3.43% | 1,183,744 | 400.05M |
| 440 | TECX | Tectonic Therapeutic, Inc. | 577.59M | 0.79% | 160,857 | - |
| 441 | ALT | Altimmune, Inc. | 575.64M | 6.86% | 4,060,013 | 36.00K |
| 442 | ZVRA | Zevra Therapeutics, Inc. | 574.01M | 1.89% | 1,713,002 | 122.29M |
| 443 | SPRY | ARS Pharmaceuticals, Inc. | 571.99M | -3.03% | 1,819,888 | 98.99M |
| 444 | SLN | Silence Therapeutics plc | 570.11M | 9.53% | 666,332 | 839.00K |
| 445 | CTKB | Cytek Biosciences, Inc. | 569.52M | -1.12% | 521,402 | 204.17M |
| 446 | ANGO | AngioDynamics, Inc. | 564.60M | 0.52% | 403,100 | 320.17M |
| 447 | FLGT | Fulgent Genetics, Inc. | 556.08M | -0.46% | 221,329 | 320.35M |
| 448 | RLMD | Relmada Therapeutics, Inc. | 545.43M | 0.39% | 899,010 | - |
| 449 | PRME | Prime Medicine, Inc. | 543.66M | 2.03% | 2,614,535 | 4.03M |
| 450 | FDMT | 4D Molecular Therapeutics, Inc. | 542.63M | 3.08% | 531,420 | 88.24M |
| 451 | STTK | Shattuck Labs, Inc. | 539.83M | -5.25% | 948,130 | 1.00M |
| 452 | EIKN | Eikon Therapeutics, Inc. | 534.89M | 11.01% | 289,995 | - |
| 453 | VSTM | Verastem, Inc. | 534.27M | 0.50% | 2,244,216 | 49.59M |
| 454 | ARVN | Arvinas, Inc. | 530.36M | 2.37% | 475,560 | 89.40M |
| 455 | WEAV | Weave Communications, Inc. | 529.11M | 7.78% | 975,854 | 248.72M |
| 456 | NPCE | NeuroPace, Inc. | 521.63M | 3.31% | 143,346 | 99.53M |
| 457 | TOI | The Oncology Institute, Inc. | 518.91M | 4.22% | 1,450,741 | 545.76M |
| 458 | CTNM | Contineum Therapeutics, Inc. | 518.18M | -1.42% | 114,170 | - |
| 459 | RZLT | Rezolute, Inc. | 516.07M | -1.00% | 1,245,382 | - |
| 460 | MYGN | Myriad Genetics, Inc. | 514.74M | -2.85% | 1,172,183 | 829.00M |
| 461 | ZURA | Zura Bio Limited | 511.09M | 2.87% | 384,617 | - |
| 462 | KIDS | OrthoPediatrics Corp. | 509.08M | 5.03% | 117,041 | 243.30M |
| 463 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 464 | ARTV | Artiva Biotherapeutics, Inc. | 501.43M | 2.89% | 281,331 | 251.00K |
| 465 | ASMB | Assembly Biosciences, Inc. | 498.79M | 1.41% | 79,180 | 71.10M |
| 466 | DNA | Ginkgo Bioworks Holdings, Inc. | 486.67M | 1.22% | 576,452 | 151.40M |
| 467 | ANL | Adlai Nortye Ltd. | 482.40M | -3.52% | 127,850 | 5.00M |
| 468 | KYTX | Kyverna Therapeutics, Inc. | 481.50M | 6.88% | 1,194,596 | - |
| 469 | OFIX | Orthofix Medical Inc. | 481.02M | 5.78% | 284,632 | 825.37M |
| 470 | TLRY | Tilray Brands, Inc. | 480.71M | 3.87% | 3,718,883 | 858.28M |
| 471 | NRC | NRC Health | 479.36M | 1.09% | 57,630 | 138.64M |
| 472 | HELP | Cybin Inc. | 477.28M | 1.05% | 1,013,492 | - |
| 473 | SOPH | SOPHiA GENETICS SA | 474.01M | -1.22% | 251,401 | 81.18M |
| 474 | AQST | Aquestive Therapeutics, Inc. | 467.99M | 1.36% | 1,814,779 | 50.27M |
| 475 | PROK | ProKidney Corp. | 465.17M | 2.67% | 1,244,471 | 889.00K |
| 476 | VALN | Valneva SE | 465.11M | 3.77% | 4,481 | 180.25M |
| 477 | VMD | Viemed Healthcare, Inc. | 464.64M | 2.97% | 256,719 | 286.57M |
| 478 | VREX | Varex Imaging Corporation | 462.77M | 0.55% | 337,592 | 857.50M |
| 479 | SGMT | Sagimet Biosciences Inc. | 460.05M | 5.37% | 544,061 | - |
| 480 | IKT | Inhibikase Therapeutics, Inc. | 459.24M | 0.86% | 513,873 | 1.00 |
| 481 | PRTA | Prothena Corporation plc | 455.47M | -0.57% | 704,707 | 57.94M |
| 482 | MPLT | MapLight Therapeutics, Inc. | 449.15M | -72.91% | 8,148,125 | - |
| 483 | NNNN | Anbio Biotechnology | 446.81M | 2.83% | 14,334 | 8.65M |
| 484 | SLBT | SL Science Holding Limited | 446.09M | -11.54% | 143,393 | 3.36M |
| 485 | SRTA | Strata Critical Medical, Inc. | 444.75M | 1.98% | 1,252,509 | 228.58M |
| 486 | CABA | Cabaletta Bio, Inc. | 443.51M | 1.12% | 2,185,449 | - |
| 487 | OVID | Ovid Therapeutics Inc. | 438.60M | 0.86% | 1,048,328 | 7.12M |
| 488 | CLPT | ClearPoint Neuro, Inc. | 437.85M | 3.40% | 324,537 | 40.61M |
| 489 | SI | Shoulder Innovations, Inc. | 434.67M | 2.69% | 51,568 | 53.89M |
| 490 | EVH | Evolent Health, Inc. | 428.55M | -9.72% | 6,157,161 | 1.89B |
| 491 | OCGN | Ocugen, Inc. | 426.54M | 4.13% | 5,037,488 | 4.47M |
| 492 | PACB | Pacific Biosciences of California, Inc. | 422.42M | - | 6,750,945 | 160.03M |
| 493 | EVMN | Evommune, Inc. | 413.13M | 0.97% | 316,457 | 10.00M |
| 494 | DCTH | Delcath Systems, Inc. | 412.19M | -2.29% | 439,544 | 90.44M |
| 495 | EDIT | Editas Medicine, Inc. | 411.28M | 3.08% | 937,273 | 38.69M |
| 496 | EOLS | Evolus, Inc. | 406.98M | 3.34% | 650,245 | 301.79M |
| 497 | PBYI | Puma Biotechnology, Inc. | 406.69M | 0.13% | 143,867 | 227.18M |
| 498 | CAPR | Capricor Therapeutics, Inc. | 405.09M | -64.49% | 29,995,426 | 11.13M |
| 499 | EPRX | Eupraxia Pharmaceuticals Inc. | 404.59M | 6.20% | 326,170 | - |
| 500 | KMDA | Kamada Ltd. | 399.79M | -0.99% | 37,862 | 181.68M |